JP2000004715A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000004715A5 JP2000004715A5 JP1998173629A JP17362998A JP2000004715A5 JP 2000004715 A5 JP2000004715 A5 JP 2000004715A5 JP 1998173629 A JP1998173629 A JP 1998173629A JP 17362998 A JP17362998 A JP 17362998A JP 2000004715 A5 JP2000004715 A5 JP 2000004715A5
- Authority
- JP
- Japan
- Prior art keywords
- plasmid dna
- btx
- electroporation
- reported
- san diego
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 6
- 108010002616 Interleukin-5 Proteins 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 210000004369 Blood Anatomy 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 108060001084 Luciferase family Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 210000002966 Serum Anatomy 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cells Anatomy 0.000 description 1
- 230000023298 conjugation with cellular fusion Effects 0.000 description 1
- 210000004748 cultured cells Anatomy 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 210000002257 embryonic structures Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 210000000663 muscle cells Anatomy 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 238000007500 overflow downdraw method Methods 0.000 description 1
- 230000005700 syncytium formation by plasma membrane fusion Effects 0.000 description 1
- 210000004881 tumor cells Anatomy 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10173629A JP2000004715A (ja) | 1998-06-19 | 1998-06-19 | 脊椎動物への遺伝子導入発現方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10173629A JP2000004715A (ja) | 1998-06-19 | 1998-06-19 | 脊椎動物への遺伝子導入発現方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000004715A JP2000004715A (ja) | 2000-01-11 |
| JP2000004715A5 true JP2000004715A5 (fr) | 2004-08-05 |
Family
ID=15964164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10173629A Pending JP2000004715A (ja) | 1998-06-19 | 1998-06-19 | 脊椎動物への遺伝子導入発現方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000004715A (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4536233B2 (ja) * | 2000-09-01 | 2010-09-01 | 独立行政法人科学技術振興機構 | 遺伝子導入動物の製造方法 |
| WO2002066069A1 (fr) * | 2001-02-20 | 2002-08-29 | Kansai Technology Licensing Organization Co., Ltd. | Remedes contre l'inflammation/les maladies tumorales |
-
1998
- 1998-06-19 JP JP10173629A patent/JP2000004715A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115651927B (zh) | 编辑rna的方法和组合物 | |
| WO2002092764A3 (fr) | Modele de modulation de la masse osseuse d'un'animal transgenique | |
| MXPA03010077A (es) | Abonadora de siembra a voleo con deflector movible. | |
| WO2002031134A3 (fr) | Nouveaux genes de serine protease apparentes a la dppiv | |
| DE69937243D1 (de) | Überexpression von gewünschten proteinen in eukaryotischen zellen mittels überexpression von cyclin d1 | |
| JP2003517580A5 (fr) | ||
| ATE338821T1 (de) | Strukturprotein von aav, seine herstellung und verwendung | |
| EP1798239A3 (fr) | Récepteurs de protéine G-couplés et utilisations correspondantes | |
| TW200516144A (en) | Novel bone mineralization proteins, DNA, vectors, expression systems | |
| BRIAND et al. | Nucleotide Sequence (n= 159) of the Amino‐Acid‐Accepting 3′‐OH Extremity of Turnip‐Yellow‐Mosaic‐Virus RNA and the Last Portion of Its Coat‐Protein Cistron | |
| IL173399A0 (en) | Circular dna molecule with conditional origin of replication which contains nucleic acid of interest and selection marker but does not encode its replication initiation protein, method for preparing the same and use thereof in gene therapy | |
| WO2000027994A3 (fr) | Sequence genomique de chlamydia pneumoniae | |
| EP0701563A4 (fr) | Transfert genique destine au traitement de tissus conjonctifs chez un mammifere hote | |
| ATE331802T1 (de) | Sequenz-spezifische dna-rekombination in eukaryotischen zellen | |
| CN113677793A (zh) | 稳定的crispr复合物 | |
| HUP9800329A2 (hu) | Nukleinsavkonstrukciók strukturális gének sejtciklus-függő módon szabályozott expresszálására | |
| CN112430597A (zh) | 一种使目的基因沉默的CasRx制剂及其应用 | |
| WO1999023216A3 (fr) | Vecteurs d'expression inductible par hyperthermie utiles pour la therapie genique et procedes d'utilisation de ceux-ci | |
| CN113874503A (zh) | 用于调节crispr活性的系统和方法 | |
| WO1997026322A3 (fr) | Compositions et procedes d'inhibition de l'hexokinase | |
| Wariishi et al. | A SP1 binding site in the GC-rich region is essential for a core promoter activity of the human endothelial nitric oxide synthase gene | |
| WO2002090524A3 (fr) | Molecules d'acides nucleiques isolees codant pour des proteines humaines codees par la kinase mapkap-2 a transduction de signal, cellules ainsi transformees et utilisations | |
| WO2001019966A3 (fr) | Isolation de cellules souches derivees de muscle et utilisations associees | |
| BR9811014A (pt) | "região concentrada reguladora de gene especìfica para semente precoce" | |
| JP2000004715A5 (fr) |